Glioblastoma (GBM) stands out as the most common, aggressive form of primary malignant
brain tumor conferring a devastatingly poor prognosis. Despite aggressive standard-of-care …

Glioblastoma (GBM) is the most common primary malignant brain tumour in adults. Despite
the combination of novel therapeutical approaches, it remains a deadly malignancy with an …

Glioblastoma (GBM) is characterized by aggressive growth and high rates of recurrence.
Despite the advancements in conventional therapies, the prognosis for GBM patients …

Background Gliomas are the most common malignant brain tumors, with powerful
invasiveness and an undesirable prognosis. Actin related protein 2/3 complex subunit 5 …

Glioblastoma (GBM) is a highly aggressive primary brain tumor that is largely refractory to
treatment and, therefore, invariably relapses. GBM patients have a median overall survival of …

Background: Autophagy, a process of self-digestion, is closely related to multiple biological
processes of colon cancer. This study aimed to construct and evaluate prognostic signature …

Malignant brain tumors are highly heterogeneous tumors with a poor prognosis and a high
morbidity and mortality rate in both children and adults. The cancer stem cell (CSC, also …

Background N6-methyladenosine (m6A) RNA methylation regulators play crucial role in
tumorigenicity and progression. However, their biological significance in primary …

Background Protein tyrosine phosphatase non-receptor type 1 (PTPN1), a member of the
protein tyrosine phosphatase superfamily, has been identified as an oncogene and …

The tumor immune microenvironment (TIME) has been recognized to be associated with
sensitivity to immunotherapy and patient prognosis. Recent research demonstrates that …